Archives: “Archives”

Shaye Kivity, MD

Senior Lecturer, Meir Medical Center, Tel Aviv UniversityInternal Medicine (Rheumatology) Dr. Shaye Kivity is Head of the Rheumatology Department and Director of the Research Authority at Meir Medical Center, affiliated […]

Mohammad Haj Dezfulian, PhD

Assistant Professor, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania Dr. Mohammad Haj Dezfulian is Assistant Professor of Pathology and Laboratory Medicine at the Perelman […]

Stefan Feske, MD

Vice Chair for Research, Department of Pathology, NYU Grossman School of Medicine / NYU Langone Health Jeffrey Bergstein Professor of Medicine, Department of Pathology, NYU Grossman School of Medicine / NYU […]

Jill P. Buyon, MD

Sir Deryck and Lady Va Maughan Professor of Rheumatology, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health Director, Division of Rheumatology, NYU Grossman School of Medicine […]

Comprehensive Mapping of Antigenic Landscapes in Sjögren’s Disease Using Enhanced T-Scan Technology

Mapping the full antigenic landscape of Sjögren's disease using T-Scan technology to identify the drivers of autoimmune T cell responses and enable targeted therapies.

Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade

Machine learning approach to single cell transcriptomic analysis of Sjogren’s disease reveals altered activation states of B and T lymphocytes

IFN-γ–producing TH1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjögren’s disease

New Hope for Sjögren’s Disease Patients: NYU Study Links Calcium Signaling and T Cell Dysfunction to the Condition

A Colton-supported NYU study published in Science Translational Medicine has identified impaired regulatory T cells as a key driver of Sjögren's disease — and found a promising existing drug as a potential therapy.

NYU Langone Joins $58M NIH Partnership to Accelerate Autoimmune Disease Research

NYU Langone's Colton-backed Division of Rheumatology is taking a leading role in the NIH's $58 million AMP AIM program, driving research into lupus, psoriatic disease, Sjögren's disease, and the microbiome.